People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Other Health Care, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sonendo, Inc. | — | Other Health Care | Series C | $241.5M | $33.0M | 2008 |
| Adagio Medical, Inc. | — | Healthtech | Series C | $81.6M | $128.1M | 2013 |
| GLAUKOS Corp | — | Other Health Care | Series B | $76.0M | $664.6M | 2010 |
| Metronom Health, Inc. | — | Healthtech | Series B | $48.6M | $476.9M | 2014 |
| Prelude Corp | — | Biotechnology | Series A | $40.9M | $13.8M | 2016 |
| YAP Therapeutics Inc | — | Biotechnology | Series B | $30.1M | $618.3M | 2022 |
| LoneStar Heart, Inc. | — | Other Health Care | Series A | $25.2M | $84.4M | 2010 |
| CardioPolymers, Inc. | — | Other Health Care | Series A | $13.6M | $273.9M | 2009 |
| Anaxiom Corp | — | Other Health Care | Series A | $9.5M | $19.7M | 2016 |
| Otello Medical, Inc. | — | Healthtech | Seed | $1.6M | $45.5M | 2018 |
| Orqis Medical Corp | — | Other Health Care | Seed | $1.2M | $29.6M | 2008 |
| Arges Imaging Inc. | — | Other Health Care | Pre-Seed | $855K | $26.4M | 2010 |
| Siqro, Inc. | — | Other Health Care | Pre-Seed | $676K | $20.8M | 2009 |
Olav B. Bergheim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Olav B. Bergheim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hugh B. Neuharth | 7 | 7 |
| Andrew B. Wade | 3 | 3 |
| William J. Link | 2 | 10 |
| Raymond W. Cohen | 2 | 5 |
| Hugh Neuharth | 2 | 2 |
| Charles Chungsik Chon | 2 | 2 |
| Hugh A. Neuharth | 2 | 2 |
| Olav Bergheim | 2 | 2 |
| Mark Leschly | 1 | 9 |
| Brian Dovey | 1 | 7 |
| James Cox | 1 | 6 |
| Dennis Costello | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Gilbert H. Kliman | 1 | 5 |
| Morteza Gharib | 1 | 5 |
| CHARLES CHON | 1 | 5 |
| David Nikodem | 1 | 4 |
| Kenneth Charhut | 1 | 4 |
| Fan Yu | 1 | 4 |
| Roderick De Greef | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.